Robert W. Zucker serves as Executive at Organicell Regenerative Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Robert W. Zucker has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 15, 2020 involved receiving (via award) 736,808 shares valued at $14.7K.
Robert W. Zucker currently holds 5,736,808 shares of Organicell Regenerative Medicine, Inc. (BPSR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert W. Zucker has been a net neutral trader of BPSR stock. They have purchased $0 and sold $0 worth of shares.
Robert W. Zucker's most recent insider trade was on Apr 15, 2020, when they sold 736,808 shares at $0.02 per share.
Get notified when new Form 4 filings are submitted
| $0.03 |
| Discretionary |